SCICLONE PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
25 Oct 2016	Form 3: Chern Carey, General Counsel No securities owned
02 Mar 2016	Form 3: Dragon Alpha Lp, See Remarks and 2 others Holds 8,888 shares of Common Stock, par value $0.001 per share ("Common Stock")
01 Mar 2016	Form 3: Ally Bridge Lb Healthcare Master Fund Ltd, Member of 10% owner group and 4 others Holds 678,077 shares of Common Stock
26 Feb 2016	Form 3: Gl Partners Capital Management Ltd, 10% owner and 1 other Holds 4,750,116 shares of Common Stock, par value $0.001 per share
02 Mar 2015	Form 3: King Robert, SVP of Prod Devp/ Supply Chain Holds 12,582 shares of Common Stock
19 Feb 2014	Form 3: Meng Chuncai, Gen. Counsel & VP Compliance No securities owned
16 Oct 2013	Form 3: Low Raymond Anthony, VP, Finance & Controller
19 Sep 2013	Form 3: Chang Nancy T, Director
09 Aug 2013	Form 3: Tso Winnie Wing-Kei, VP, Finance and Controller
22 Jul 2013	Form 3: Cheung Wilson Wai-Shun, CFO & Senior VP, Finance No securities owned
10 May 2013	Form 3: Zhao Hong, CEO, China Operations
21 Feb 2013	Form 3: Li Simon, Director
10 Aug 2012	Form 3: Wong Stephanie, VP, Finance and Controller Holds 2,000 shares of Common Stock
10 Aug 2012	Form 3: Xie Lan, VP Finance China, CFO
19 Jun 2012	Form 3: Guan Jie Jackie, Chief Operating Officer
14 Jun 2012	Form 3: Yin Min, See Remarks
21 Apr 2011	Form 3: Lotter Mark, Director Holds 1,629,316 shares of Common Stock
20 Apr 2011	Form 3: Barrett Peter, Director Holds 1,972,189 shares of Common Stock
01 Jul 2010	Form 3: Sinaf S.a., Member of 10% owner group Holds 1,289,052 shares of Common Stock
01 Jul 2010	Form 3: Aptafin S P A, Member of 10% owner group Holds 765,841 shares of Common Stock

Comments